Dementia now striking people in their 40s as mercury from vaccines causes slow, degenerative brain damage

September 1, 2015November 20, 2020 ~ admin ~ 4 Comments

David Gutierrez – Dementia and other neurological brain diseases are striking people younger and younger, according to a new study conducted by researchers from Bournemouth University in England and published in the journal Surgical Neurology International. These diseases have reached levels that are “almost epidemic,” the researchers said, and they reached them so quickly that environmental factors must be largely to blame.

“The rate of increase in such a short time suggests a silent or even a ‘hidden’ epidemic, in which environmental factors must play a major part, not just ageing,” lead researcher Colin Pritchard said. “Modern living produces multi-interactional environmental pollution but the changes in human morbidity, including neurological disease is remarkable and points to environmental influences.”

Death rates have more than doubled

The researchers compared the rates of neurological brain diseases in 21 Western countries from 1989 to 2010. They found that as of 2010, the average rate of onset for dementia was 10 years earlier than it was in 1989. In addition, deaths from neurological disease had increased significantly in people aged 55 to 74 and had nearly doubled in people aged 75 and older. Continue reading →

Simple Amoeba Can Help Fight Alzheimer – Research

January 28, 2014March 28, 2019 ~ admin ~ Leave a comment

RT January 26 2014

Scientists have discovered a way to study the causes of Alzheimer disease using a simple single-celled amoeba, which leads to a better understanding of how human proteins mutate. It circumvents the need for animal testing.

British scientists point to the possibility of amoeba use in biomedical studies of the presenilin protein that plays a part in causing Alzheimer disease, widespread among the elderly. A press release about the study by researchers from the Royal Holloway University of London and the Institute of Psychiatry of King’s College, London, was published in the Journal of Cell Science on Friday.

It reveals that the so-called ‘social’ amoeba has become an essential source in the understanding of how human proteins function, whose mutations are associated with the development of dementia. It could lead to the creation of a new generation of treatments for this incurable disease.

Professor Robin Williams, a scientist from Royal Holloway, University of London elaborates on the idea of using amoeba in medical research of epilepsy, saying, “This discovery allows us to examine the role for the human presenilin 1 protein, without the use of animal testing. It is amazing that so simple an organism lends itself to the study of such a complex disease”.

Continue reading →

Research Shows B Vitamins Slow Alzheimer’s Progression

December 13, 2013September 25, 2020 ~ admin ~ Leave a comment

NaturalSociety December 12 2013

Researchers with Oxford’s Nuffield Department of Clinical Neurosciences have discovered that low blood serum levels of B vitamins could lead to a more significant decrease in grey matter atrophy of the brain, speeding the cognitive decline associated with Alzheimer’s disease. In other words, some of the most recent findings on diet and Alzheimer’s prevention is related to the family of B vitamins, and how upping intake could slow Alzheimer’s progression.

The researchers conducted a clinical trial with more than 150 elderly patients who had mild impairment and a high risk of Alzheimer’s disease and dementia. For two years, one group received B vitamin supplementation, including 800 mg folic acid, 20 mg B6, and 500 mg B12. The other group received a placebo.

Using MRI technology, the participants’ brains were mapped prior, during, and after the two year study period. Specifically, the researchers were looking at the amount of grey matter within the brain. Grey matter shrinks with the development of Alzheimer’s disease and age-related cognitive decline.

In both groups, grey matter shrunk over the two year study period. However, those given B vitamin supplements saw seven times less grey matter shrinkage than the other group who received no supplementation.

The researchers believe the B vitamin supplements had a direct effect on homocysteine levels. Homocysteine is an amino acid. High levels are associated with an increased risk of heart disease, strokes, and Alzheimer’s disease. It seems that B vitamins should be added to the list of things you should be eating to protect your brain as it ages.